Acarbose and Stroke - a phase IV clinical study of FDA data

Summary:

Stroke is reported as a side effect among people who take Acarbose (acarbose), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Gliclazide, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Stroke when taking Acarbose. It is created by eHealthMe based on reports of 4,551 people who have side effects when taking Acarbose from the FDA, and is updated regularly.

What is Acarbose?

Acarbose has active ingredients of acarbose. It is often used in diabetes. eHealthMe is studying from 4,605 Acarbose users. Check the latest studies of Acarbose.

What is Stroke?

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 2,458 drugs and 3,004 conditions by eHealthMe. Check the latest studies of Stroke.

On Sep, 19, 2025

4,551 people reported to have side effects when taking Acarbose.
Among them, 59 people (1.3%) have Stroke.

Among these 59 people:

How long have people been on Acarbose when they have Stroke? *

What is the gender of people who have Stroke when taking Acarbose? *

female: 17.86 %
male: 82.14 %

What is the age of people who have Stroke when taking Acarbose? *

What are other drugs people take besides Acarbose? *

What are other side effects people have besides Stroke? *

Speech Disorder: 27 people, 45.76%
Nervous System Disorder (a general class of medical conditions affecting the nervous system): 26 people, 44.07%
Speech Impairment (Adult) (inability to speak (adult)): 26 people, 44.07%
Chest Pain: 25 people, 42.37%
Hemiparesis (weakness on one side of the body): 25 people, 42.37%
High Blood Pressure: 25 people, 42.37%
Monoparesis (one limb is very weak, but not completely paralyzed): 22 people, 37.29%
Quadriparesis (muscle weakness affecting all four limbs): 14 people, 23.73%
Quadriplegia (a four limb paralysis): 12 people, 20.34%
Memory Loss: 4 people, 6.78%

What are the existing conditions these people have? *

Type 2 Diabetes: 9 people, 15.25%
High Blood Pressure: 6 people, 10.17%
Prostatic Disorder: 3 people, 5.08%
Hypersensitivity: 3 people, 5.08%
Nausea (feeling of having an urge to vomit): 3 people, 5.08%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 5.08%
Headache (pain in head): 3 people, 5.08%
Pain: 3 people, 5.08%
Sedation: 3 people, 5.08%
Multiple Myeloma (cancer of the plasma cells): 2 people, 3.39%

* Approximation only. Some reports may have incomplete information.

Do you take Acarbose and have Stroke?

- Check whether Stroke is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Acarbose:

Acarbose (4,605 reports)

Stroke treatments and more:

Stroke (334,630 reports)

How severe was Stroke and when was it recovered:

Stroke in Acarbose

Browse all side effects of Acarbose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stroke:

Stroke (2,458 drugs)

Browse all the conditions that are associated with Stroke:

Stroke (3,004 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acarbose (the active ingredients of Acarbose) and Acarbose (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.